Longeveron LGVN
NASDAQ LGVN
$0.84 +0.02 (+2.02%)
At close: Aug 21, 2026 · 4:00 PM EDT

Longeveron (LGVN) Revenue (2020 - 2026)

Longeveron (LGVN) posted quarterly Revenue of $398000.0 for Q1 2026, up 4.46% year-over-year from $381000.0 in Q1 2025, and up 9.04% quarter-over-quarter from $365000.0 in Q4 2025.

Longeveron (LGVN) Revenue (2020 - 2026) Analysis & Trends

Longeveron's Revenue history runs 7 years deep, the most recent figure standing at $398000.0 for Q1 2026.

  • In Q1 2026, Revenue rose 4.46% year-over-year to $398000.0; the TTM figure through Mar 2026 stood at $1.2 million (down 45.35% YoY), while the FY2025 annual figure was $1.2 million, down 49.87% from the prior year.
  • Revenue for Q1 2026 stood at $398000.0, up from $365000.0 in the prior quarter.
  • The five-year high for Revenue was $773000.0 in Q3 2024, with the low at $63000.0 in Q4 2023.
  • The 5-year median for Revenue is $316000.0 (2025), against an average of $335000.0.
  • The sharpest annual moves came in 2024 and 2025: Revenue soared 857.14% in 2024, then sank 82.28% in 2025.
  • Longeveron's Revenue stood at $121000.0 in 2022, then tumbled by 47.93% to $63000.0 in 2023, then jumped by 857.14% to $603000.0 in 2024, then plunged by 39.47% to $365000.0 in 2025, then gained by 9.04% to $398000.0 in 2026.
  • Business Quant data shows LGVN's Revenue at $398000.0 in Q1 2026, $365000.0 in Q4 2025, and $137000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 3.33 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 4.29 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.52 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 145.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.71 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.29 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 1.06 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 425.49 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 674.14 Mn
10 Longeveron 26.51 Mn 16.41 Mn 182,000.00 287,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 287,000.00
Mar 31, 2026 398,000.00
Dec 31, 2025 365,000.00
Sep 30, 2025 137,000.00
Jun 30, 2025 316,000.00
Mar 31, 2025 381,000.00
Dec 31, 2024 603,000.00
Sep 30, 2024 773,000.00
Jun 30, 2024 468,000.00
Mar 31, 2024 548,000.00
Dec 31, 2023 63,000.00
Sep 30, 2023 150,000.00
Jun 30, 2023 217,000.00
Mar 31, 2023 279,000.00
Dec 31, 2022 121,000.00
Sep 30, 2022 100,000.00
Jun 30, 2022 466,000.00
Mar 31, 2022 310,000.00
Dec 31, 2021 209,000.00
Sep 30, 2021 232,000.00